Patrizia Cavazzoni, head of FDA’s drug center, to leave the agency
Patrizia Cavazzoni, leader of the FDAs Center for Drug Evaluation and Research, is leaving the agency on Jan. 18
Related Articles
Message Reminders to Improve Adherence to Chronic Cardiovascular Medications
This randomized clinical trial compares different text messaging strategies (generic refill reminders, behavioral nudge refill reminders, behavioral nudge refill reminders plus a fixed-message chatbot) with…
Oncology With Sadie Dobrozsi, MD
Dr. Dobrozsi is the Medical Director of Genetic Testing & Oncology Imaging at Evolent, a specialty and primary care management company. She is nationally recognized…
Climate Change Threatens the Mental Well-Being of Youths. Here’s How To Help Them Cope. – KFF Health News
The growing toll of climate-related disasters is a risk to the emotional well-being of young people. An Orange County, California, pediatric emergency doctor wants to…
Atumelnant Reduces Key CAH Biomarkers, Hits Primary Phase 2 Endpoint
Atumelnant rapidly lowered key biomarkers in congenital adrenal hyperplasia in positive topline results from the Phase 2 TouCAHn trial.
Four Clinical Trials We’re Watching That Could Change Medicine in 2025
What new medicines are poised to take the leap from breakthrough to approval in 2025? Here’s what to expect this year.
Why Emotional Intelligence Is the Key to High-Impact Leadership
Why emotional intelligence is essential for modern leadership and how to cultivate it to drive results and inspire your team.
Research: Consumers Don’t Want AI to Seem Human
Making your AI tools look human or dehumanizing them altogether are not the best ways to win over your users. Instead, show them the human…
Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells
CAR signaling domains determine molecular dynamics at the immune synapse and consequently influence CAR T cell killing behavior.
Fighting for physicians
The AMA is your powerful ally, focused on addressing the issues important to you, so you can focus on what matters most—patients.
A new credit card for NYC millionaires has over 30,000 people on the waitlist
In a tough time for fintech, Atlas is looking to beat the odds by building a business focused on serving high-net-worth individuals. Fortune can exclusively…